Nasdaq Bctx News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq bctx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq Bctx Today - Breaking & Trending Today
Concord Wealth Partners trimmed its holdings in shares of BriaCell Therapeutics Corp. (NASDAQ:BCTX – Free Report) by 29.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,775 shares of the company’s stock after selling 4,500 shares during the period. Concord Wealth Partners’ holdings […] ....
HC Wainwright reiterated their buy rating on shares of BriaCell Therapeutics (NASDAQ:BCTX – Free Report) in a report released on Thursday, Benzinga reports. They currently have a $18.00 price target on the stock. BriaCell Therapeutics Price Performance Shares of BriaCell Therapeutics stock opened at $5.85 on Thursday. BriaCell Therapeutics has a 1 year low of […] ....
Wasatch Advisors LP reduced its position in shares of BriaCell Therapeutics Corp. (NASDAQ:BCTX – Free Report) by 0.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 612,088 shares of the company’s stock after selling 3,990 shares during the period. Wasatch Advisors […] ....
BriaCell Therapeutics (NASDAQ:BCTX – Free Report) and Aadi Bioscience (NASDAQ:AADI – Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends. Insider & Institutional Ownership 16.1% of BriaCell Therapeutics shares […] ....
BriaCell Therapeutics (NASDAQ:BCTX – Free Report) and Aadi Bioscience (NASDAQ:AADI – Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends and analyst recommendations. Volatility and Risk BriaCell Therapeutics has a beta of […] ....